Tumor necrosis factor-alpha gene promoter methylation in Japanese adults with chronic periodontitis and rheumatoid arthritis

Journal of Periodontal Research

Volumn 51, Issue 3, 2016, Pages 350-358

  Kojima, A ^a   Kobayashi, T ^a,b   Ito, S ^c   Murasawa, A ^c   Nakazono, K ^c   Yoshie, H ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^c Niigata Rheumatic Center   (Japan)

Author keywords

DNA methylation; Periodontitis; Rheumatoid arthritis; Tumor necrosis factor alpha

Indexed keywords

CYTIDYLYL-3'-5'-GUANOSINE; DINUCLEOSIDE PHOSPHATE; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

AGED; BLOOD; CHRONIC PERIODONTITIS; CLASSIFICATION; DNA METHYLATION; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; JAPAN; MALE; MIDDLE AGED; MONONUCLEAR CELL; NUCLEOTIDE MOTIF; NUCLEOTIDE SEQUENCE; PERIODONTAL DISEASE; PERIODONTAL POCKET; PORPHYROMONAS GINGIVALIS; PROMOTER REGION; RHEUMATOID ARTHRITIS;

AGED; ARTHRITIS, RHEUMATOID; BASE SEQUENCE; CHRONIC PERIODONTITIS; DINUCLEOSIDE PHOSPHATES; DNA METHYLATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGLOBULIN G; JAPAN; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; NUCLEOTIDE MOTIFS; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; PORPHYROMONAS GINGIVALIS; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84938897075     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/jre.12314     Document Type: Article

References (56)

1. Bartold PM, Marshall RI, Haynes DR. Periodontitis and rheumatoid arthritis: a review. J Periodontol 2005;76:2066-2074.
2. de Pablo P, Chapple ILC, Buckley CD, Dietrich T. Periodontitis in systemic rheumatic diseases. Nat Rev Rheumatol 2009;5:218-224.
3. Kässer UR, Gleissner C, Dehne F, Michel A, Willershausen-Zönnchen B, Bolten WW. Risk for periodontal disease in patients with longstanding rheumatoid arthritis. Arthritis Rheum 1997;40:2248-2251.
4. Havemose-Poulsen A, Westergaard J, Stoltze K et al. Periodontal and hematological characteristics associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. J Periodontol 2006;77:280-288.
5. Pischon N, Pischon T, Kröger J et al. Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol 2008;79:979-986.
6. Dissick A, Redman RS, Jones M et al. Association of periodontitis with rheumatoid arthritis: a pilot study. J Periodontol 2010;81:223-230.
7. Mercado F, Marshall RI, Klestov AC, Bartold PM. Is there a relationship between rheumatoid arthritis and periodontal disease? J Clin Periodontol 2000;27:267-272.
8. Demmer RT, Molitor JA, Jacobs DR Jr., Michalowicz BS. Periodontal disease, tooth loss and incident rheumatoid arthritis: results from the First National Health and Nutritional Examination Survey and its epidemiological follow-up study. J Clin Periodontol 2011;38:998-1006.
9. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007;7:429-442.
10. Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003;74:391-401.
11. Tervahartiala T, Koski H, Xu J-W et al. Tumor necrosis factor-alpha and its receptors, p55 and p75, in gingiva of adult periodontitis. J Dent Res 2001;80:1535-1539.
12. Górska R, Gregorek H, Kowalski J, Laskus-Perendyk A, Syczewska M, Madaliński K. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. J Clin Periodontol 2003;30:1046-1052.
13. Kurtiş B, Tüter G, Serdar M et al. Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis. J Periodontol 2005;76:1849-1855.
14. Havemose-Poulsen A, Sørensen LK, Stoltze K, Bendtzen K, Holmstrup P. Cytokine profiles in peripheral blood and whole blood cell cultures of patients associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. J Periodontol 2005;76:2276-2285.
15. Kobayashi T, Murasawa A, Komatsu Y et al. Serum cytokine and periodontal profiles in relation to disease activity of rheumatoud arthritis in Japanese adults. J Periodontol 2010;8:650-657.
16. Shapira L, Takashiba S, Champagne C, Amar S, Van Dyke TE. Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-α and IL-1β production by human monocytes. J Immunol 1994;153:1818-1824.
17. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-3199.
18. Wilson AG. Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases. J Periodontol 2008;79:1514-1519.
19. Sullivan KE, Reddy ABM, Dietzmann K et al. Epigenetic regulation of tumor necrosis factor alpha. Mol Cell Biol 2007;27:5147-5160.
20. Pieper H, Evert BO, Kaut O, Riederer PF, Waha A, Wüllner U. Different methylation of the TNF-α promoter region in cortex and substantia nigra: implications for selective neuronal vulnerability. Neurobiol Dis 2008;32:521-527.
21. Campión J, Milagro FI, Goyenechea E, Martínez JA. TNF-α promoter methylation as a predictive biomarker for weight-loss response. Obesity 2009;17:1293-1297.
22. Gowers IR, Walters K, Kiss-Toth E, Read RC, Duff GW, Wilson AG. Age-related loss of CpG methylation in the tumor necrosis factor promoter. Cytokine 2011;56:792-797.
23. Hermsdorff HH, Mansego ML, Campión J, Milagro FI, Zulet MA, Martínez JA. TNF-alpha promoter methylation in peripheral white blood cells: relationship with circulating TNF-α, truncal fat and n-6 PUFA intake in young women. Cytokine 2013;64:265-271.
24. Kaut O, Ramirez A, Pieper H, Schmitt I, Jessen F, Wüllner U. DNA methylation of the TNF-α promoter region in peripheral blood monocytes and the cortex of human Alzheimer's disease patients. Dement Geriatr Cogn Disord 2014;38:10-15.
25. Zhang S, Barros SP, Moretti AJ et al. Epigenetic regulation of TNFA expression in periodontal disease. J Periodontol 2013;84:1606-1616.
26. Petronis A. Human morbid genetics revisited: relevance of epigenetics. Trends Genet 2001;17:142-146.
27. Arnett FC, Edworthy SM, Bloch DA et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324.
28. Aletaha D, Neogi T, Silman AJ et al. 2010 Rheumatoid arthritis classification criteria. An American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-2581.
29. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
30. Flemmig TF. Periodontitis. Ann Periodontol 1999;4:32-37.
31. Esen Ç, Alkan BA, Kirnap M, Akgül Ö, Işikoğlu S, Erel Ö. The effects of chronic periodontitis and rheumatoid arthritis on serum and gingival crevicular fluid total antioxidant/oxidant status and oxidative stress index. J Periodontol 2012;83:773-779.
32. Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N. Comparison of disease activity score (DAS) 28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold values. Ann Rheum Dis 2007;66:407-409.
33. Lewin J, Schmitt AO, Adorján P, Hildmann T, Piepenbrock C. Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics 2004;20:3005-3012.
34. Shidara K, Inoue E, Tanaka E et al. Comparison of the second and third generation anti-cyclic citrullinated peptide antibody assays in the diagnosis of Japanese patients with rheumatoid arthritis. Rheumatol Int 2011;31:617-622.
35. Ishida K, Kobayashi T, Ito S et al. Interleukin-6 gene promoter methylation in rheumatoid arthritis and chronic periodontitis. J Periodontol 2012;83:917-925.
36. Steer JH, Kroeger KM, Abraham LJ, Joyce DA. Glucocorticoids suppress tumor necrosis factor-α expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-(B and c-Jun-activating transcrption factor-2 binding sites in the promoter. J Biol Chem 2000;275:18432-18440.
37. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004;429:457-463.
38. Schwarz JM, Nugent BM, McCarthy MM. Developmental and hormone-induced epigenetic changes to estrogen and progesterone receptor genes in brain are dynamic across the life span. Endocrinology 2010;151:4871-4881.
39. Eguchi K, Kanai Y, Kobayashi K, Hirohayashi S. DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: its association with smoking history. Cancer Res 1997;57:4913-4915.
40. Hammons GJ, Yan Y, Lopatina NG et al. Increased expression of hepatic DNA methyltransferase in smokers. Cell Biol Toxicol 1999;15:389-394.
41. Lindroth AM, Park YJ. Epigenetic biomerkers: a step forward for understanding periodontits. J Periodontal Implant Sci 2013;43:111-120.
42. Leitman DC, Ribeiro RCJ, Mackow ER, Baxter JD, West BL. Identification of a tumor necrosis factor-responsive element in the tumor necrosis factor α gene. J Biol Chem 1991;266:9343-9346.
43. Rhoades KL, Golub SH, Economou JS. The regulation of the human tumor necrosis factor α promoter region in macrophage, T cell, and B cell lines. J Biol Chem 1992;267:22102-22107.
44. Krämer B, Meichle A, Hensel G, Chamay P, Krönke M. Characterization of an Krox-24/Egr-1-responsive element in the human tumor necrosis factor promoter. Biochim Biophys Acta 1994;1219:413-421.
45. Comb M, Goodman HM. CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res 1990;18:3975-3982.
46. mCpG methylation. Gene 1997;195:67-71.
47. Ogishima T, Shiina H, Breault JE et al. Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer. Oncogene 2005;24:6765-6772.
48. Iguchi-Ariga SMM, Schaffner W. CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev 1989;3:612-619.
49. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LBA, Duff GW. An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993;177:557-560.
50. D'Alfonso S, Momigliano Richiardi P. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994;39:150-154.
51. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS. Genetic variability in the TNF-α promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 1995;211:833-839.
52. Zimmerman PA, Guderian RH, Nutman TB. A new TNFA promoter allele identified in South American Blacks. Immunogenetics 1996;44:485-486.
53. Waldron-Lynch F, Adams C, Amos C et al. Tumor necrosis factor 5′ promoter single nucleotide polymorphisms influence susceptibility to rheumatoid arthritis (RA) in immunogenetically defined multiplex RA families. Genes Immun 2001;2:82-87.
54. Kaijzel EL, Bayley J-P, van Krugten MV et al. Allele-specific quantification of tumor necrosis factor α (TNF) transcription and the role of promoter polymorphisms in rheumatoid arthritis patients and healthy individuals. Genes Immun 2001;2:135-144.
55. Craandijk J, van Krugten MV, Verweij CL, van der Velden U, Loos BG. Tumor necrosis factor-α gene polymorphisms in relation to periodontitis. J Clin Periodontol 2002;29:28-34.
56. Brett PM, Zygogianni P, Griffiths GS et al. Functional gene polymorphisms in aggressive and chronic periodontitis. J Dent Res 2005;84:1149-1153.